Thermo Fisher will acquire Clario, a clinical trial software leader, for up to $9.4B, expanding its digital and AI-driven clinical research capabilities.

Novo Nordisk's $6.5 billion bid for Metsera tops Pfizer, escalating the race for next-generation obesity treatments and sparking legal and regulatory challenges.

Takeda seals a $1.2 billion upfront deal with Innovent Biologics for late-stage cancer therapies, positioning to expand its oncology pipeline and offset patent losses.

Galapagos will close its cell therapy unit after failing to secure a buyer, impacting 365 employees and multiple global sites. The Belgian biotech shifts focus to acquisitions and building its medicine pipeline.

BioCryst Pharmaceuticals is acquiring Astria Therapeutics in a $700 million cash-and-stock deal, aiming to challenge major players in the hereditary angioedema (HAE) drug market with a broader, dual-therapy portfolio.

AI investment in 2025 is shifting from hype and promise to tangible proof and measurable returns. Investors now require case studies and real-world data before committing funds, marking a new phase for startups and industry growth.

Novo Nordisk has struck a $2.1B licensing deal with Omeros for global rights to zaltenibart, a first-in-class MASP-3 inhibitor for rare diseases.

DUOS, a senior-focused health tech company, has raised $130 million to advance its AI-powered platform and grow payer partnerships, signaling rising demand for digital senior care solutions.

Novo Nordisk acquires Akero Therapeutics in a $4.7 billion deal, strengthening its position in the expanding MASH market and planning new treatment synergies.

Prediction markets Kalshi and Polymarket are gaining on traditional sportsbooks like DraftKings and FanDuel, leveraging a different regulatory framework to offer nationwide betting and rattling Wall Street investors.

Tesla's stock recovered on Wednesday, gaining 1.42% after a sharp drop the previous day, as investors looked past the initial disappointment over new Model Y and Model 3 variants.

Costco Wholesale Corp. announced an 8% sales increase for September 2025, reaching $26.58 billion, with a significant 26.1% surge in digitally-enabled sales.

Digital music company Believe has officially launched its global publishing division following the €47 million acquisition of Sentric Music Group, a move set to integrate publishing services for artists and labels worldwide.

Trilogy Metals Inc. shares soared after the U.S. government announced a strategic investment to secure a domestic supply of critical minerals from its Alaskan projects.

San Francisco-based Intercept Music has secured a $50 million fund to acquire artist and songwriter catalogs, leveraging proprietary technology to enhance asset value in the U.S. and Latin American markets.

Constellation Brands' Corona Sunbrew Citrus Cerveza is now the top new beer in U.S. dollar sales, successfully engaging younger drinkers despite a declining market by tapping into their flavor preferences.

Netflix’s ad-supported subscription tier is fueling major growth, according to a Seaport Research Partners analysis. The plan now accounts for nearly half of new subscribers, driving significant gains in revenue and user base.

A new IPPR report reveals that one-third of UK workers have taken sick leave after work-related drinking, highlighting a direct link between office drinking culture and the nation's productivity crisis.

As AI-generated music enters the marketplace, the traditional rules of revenue are being rewritten. Streaming platforms are shifting focus from subscriber counts to ad-supported tiers, retention strategies, and nuanced content valuation, fundamentally changing how artists and creators get paid.

Verizon has named PayPal veteran Dan Schulman as its new CEO to navigate a competitive market. Despite challenges, industry reports from 2025 reaffirm Verizon's dominance in 5G network performance and reliability.

Celebrity chef Bobby Flay warns that restaurants must set high prices just to break even, reflecting an industry-wide crisis of profitability driven by surging food, labor, and rent costs.

Chef Bobby Flay says $100 per person is now the baseline as restaurants face sharp cost increases and falling demand in 2025.

Celebrity chef Bobby Flay and industry experts explain why $100-per-person restaurant bills are the new normal, as soaring labor, food, and occupancy costs squeeze margins across the sector in 2025.

Jeffrey Bierman warns that stocks and Bitcoin are driven by fear of missing out rather than fundamentals, signaling a correction risk unless managers diversify into undervalued sectors.

Jeffrey Bierman warns a market correction is looming as stocks and bitcoin surge on hype. He says shifting funds to undervalued sectors could prevent a sharp selloff.

October brings renewed volatility concerns to Wall Street, with a government shutdown and uncertain tech earnings fueling investor angst. Analysts urge focus on fundamentals—despite seasonal fears tied to past crashes.

October 2025’s market volatility comes after April’s historic crash, signaling a correction phase rather than a new crisis. Analysts urge focus on earnings and AI demand, not fear-driven headlines.

America's economy is undergoing a rapid and dramatic transformation, a “once-a-century reset” where higher interest rates and artificial intelligence are destroying old fortunes and creating new ones at unprecedented speed.

Restaurants are facing a severe economic crisis, with soaring food and labor costs forcing them to raise menu prices simply to break even. Industry experts warn this is a battle for survival.

On International Coffee Day 2025, the global coffee community is called to action to address critical challenges threatening farmers' livelihoods, including climate change, labor shortages, and incomes below the poverty line.

Professional agencies are transforming ordinary pets into social media sensations, tapping into a pet economy projected to exceed $500 billion by 2030.

Pharmaceutical giants including Merck, AstraZeneca, and Eli Lilly have withdrawn or suspended approximately £2 billion in UK investment, citing disputes with the government over NHS drug pricing. The move threatens jobs, research, and patient access to new medicines.

Style Of Our Own (SOOO) London, a new immersive venue on Regent Street founded by Laura Youngson, is revolutionizing women's sports by offering dedicated retail, community events, and gear designed specifically for female athletes.